Literature DB >> 16387527

Control of hydatidosis.

David Heath1, Wen Yang, Tiaoying Li, Yongfu Xiao, Xingwang Chen, Yan Huang, Yun Yang, Qian Wang, Jiamin Qiu.   

Abstract

Control of hydatidosis is less effective without the support of dog-owners, and this support can only be obtained if the people have a clear understanding of the life-cycle of the hydatid parasite(s) and what risk factors contribute to human infections. Dissemination of this information is the biggest challenge for hydatid control. Participatory planning between dog-owners and community leaders should evaluate the possible control technologies, and should enable a choice of those aspects that suit the sociology and economic status of the particular community. Collection of baseline data is essential, as is on-going surveillance. Hydatid control should be mainly self-funded, which again requires the support of the dog-owner. A pilot hydatid control program for Tibetan herdsmen is described.

Entities:  

Mesh:

Year:  2006        PMID: 16387527     DOI: 10.1016/j.parint.2005.11.052

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  19 in total

Review 1.  Review on Epidemiology and Public Health Significance of Hydatidosis.

Authors:  Abebe Tesfaye Gessese
Journal:  Vet Med Int       Date:  2020-12-03

2.  Gene cloning, expression, and localization of antigen 5 in the life cycle of Echinococcus granulosus.

Authors:  Yuzhe Li; Hongxu Xu; Jiajia Chen; Wenjia Gan; Weihua Wu; Weiping Wu; Xuchu Hu
Journal:  Parasitol Res       Date:  2011-12-27       Impact factor: 2.289

3.  Community perception and knowledge of cystic echinococcosis in the High Atlas Mountains, Morocco.

Authors:  Séverine Thys; Hamid Sahibi; Sarah Gabriël; Tarik Rahali; Pierre Lefèvre; Abdelkbir Rhalem; Tanguy Marcotty; Marleen Boelaert; Pierre Dorny
Journal:  BMC Public Health       Date:  2019-01-28       Impact factor: 3.295

4.  Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Eduardo A Barron; Berenice Ninaquispe; Monica Llamosas; Manuela R Verastegui; Colin Robinson; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

5.  Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.

Authors:  Cesar M Gavidia; Armando E Gonzalez; Luis Lopera; Cesar Jayashi; Roxana Angelats; Eduardo A Barron; Berenice Ninaquispe; Lucia Villarreal; Hector H Garcia; Manuela R Verastegui; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

6.  Echinococcosis: costs, losses and social consequences of a neglected zoonosis.

Authors:  G Battelli
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

7.  A monoclonal antibody-based copro-ELISA kit for canine echinococcosis to support the PAHO effort for hydatid disease control in South America.

Authors:  Noelia Morel; Gabriel Lassabe; Susana Elola; Mauricio Bondad; Silvia Herrera; Carlos Marí; Jerold A Last; Oscar Jensen; Gualberto Gonzalez-Sapienza
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

Review 8.  A systematic review of the epidemiology of echinococcosis in domestic and wild animals.

Authors:  Belen Otero-Abad; Paul R Torgerson
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

9.  An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.

Authors:  Anne-Francoise Petavy; Carlos Hormaeche; Samia Lahmar; Hammou Ouhelli; Alejandro Chabalgoity; Thierry Marchal; Samira Azzouz; Fernanda Schreiber; Gabriela Alvite; Marie-Elisabeth Sarciron; Duncan Maskell; Adriana Esteves; Georges Bosquet
Journal:  PLoS Negl Trop Dis       Date:  2008-01-16

10.  Characterization of a surface glycoprotein from Echinococcus multilocularis and its mucosal vaccine potential in dogs.

Authors:  Hirokazu Kouguchi; Jun Matsumoto; Ryo Nakao; Kimiaki Yamano; Yuzaburo Oku; Kinpei Yagi
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.